Answers are grounded in this paper and cite their sources.
CRISPR-based disease detection has the potential to profoundly change how pathogens are detected in plant materials. However, there has been a lack of research directed into improving explicitly the CRISPR components that define these detection assays. To fill this technology gap, we have designed and optimized our CRISPR-Cas12a based detection platform by showcasing its capability of detecting a plant pathogen group of rising importance, Candidatus Phytoplasma. Most assays utilize isothermal pre-amplification steps, which may boost sensitivity yet often lead to false positives. Aiming for a pre-amplification-free assay to maintain accuracy, we screened multiple Cas12a orthologs and variants and found LbCas12a-Ultra to be the most sensitive Cas12a. We further improved the detection system by using stem-loop reporters of various sizes and found 7nt stem-loop significantly outperformed other stem-loop sizes as well as the commonly used linear reporters. When the 7nt stem-loop reporter was combined with the best-performing LbCas12a-Ultra, we found a 10-fold increase in sensitivity over the standard LbCas12a with the linear reporter detection assay. To enhance the coverage of highly diverse phytoplasmas, we tested a multiplex detection method predicted to target nearly 100% of all documented phytoplasma species on NCBI. A lateral flow assay was also developed to accommodate instrument-free detection with the optimized reagents. Our study demonstrates an improved CRISPR-Cas12a detection system that has wide applications for plant pathogen detection and can be easily integrated into almost any other Cas12a-based detection platform for boosted sensitivity.
No takes yet. Share an insight, caveat, or question.
Lagner et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: